Insider · CIK 0001247296

COWARD D SCOTT

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001247296

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−52.2K sh	—	—	5,398
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.9K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−4,694 sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,175 sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−5,398 sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.8K sh	—	—	0
2025-06-12	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,398 sh	—	—	57,562
2025-02-19	EXASEXACT SCIENCES CORPF Tax Payment	Director	FTax Payment	−667 sh	$49.63	−$33.1K	52,164
2025-02-19	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,248 sh	—	—	0
2025-02-19	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,248 sh	—	—	52,831
2024-06-13	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,939 sh	—	—	50,583
2024-06-13	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,444 sh	—	—	50,088
2024-05-01	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−67 sh	$60.15	−$4,030.05	44,644
2024-04-30	EXASEXACT SCIENCES CORPA Award	Director	AAward	+218 sh	—	—	44,711
2024-02-22	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−663 sh	$59.78	−$39.6K	44,493
2024-02-21	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−706 sh	$61.50	−$43.4K	43,122
2024-02-21	EXASEXACT SCIENCES CORPA Award	Director	AAward	+2,034 sh	—	—	45,156
2024-02-20	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,248 sh	—	—	0
2024-02-20	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,248 sh	—	—	43,828
2024-02-15	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−1,376 sh	$61.43	−$84.5K	41,580
2024-02-14	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+3,972 sh	—	—	42,956
2024-02-14	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,972 sh	—	—	0
2023-06-08	EXASEXACT SCIENCES CORPA Award	Director	AAward	+6,209 sh	—	—	38,984
2023-02-28	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−4,153 sh	$61.12	−$254K	32,775
2023-02-27	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,263 sh	—	—	0
2023-02-27	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+3,263 sh	—	—	36,928
2023-02-27	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,931 sh	—	—	33,665
2023-02-27	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,931 sh	—	—	0
2023-02-22	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−1,007 sh	$62.72	−$63.2K	27,734
2023-02-21	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,248 sh	—	—	4,495
2023-02-21	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,248 sh	—	—	28,741
2023-02-15	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−1,821 sh	$65.59	−$119K	26,493
2023-02-14	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+3,972 sh	—	—	28,314
2023-02-14	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,972 sh	—	—	3,972
2023-01-03	EXASEXACT SCIENCES CORPA Award	Director	AAward	+7,780 sh	—	—	24,342
2022-05-02	EXASEXACT SCIENCES CORPA Award	Director	AAward	+328 sh	$47.41	+$15.6K	16,562
2022-03-01	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−3,912 sh	$76.69	−$300K	16,234
2022-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,025 sh	—	—	16,883
2022-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,263 sh	—	—	3,262
2022-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,025 sh	—	—	0
2022-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+3,263 sh	—	—	20,146
2022-02-25	EXASEXACT SCIENCES CORP · Restricted Stock UnitsA Award	Director	AAward	+5,931 sh	—	—	5,931
2022-02-24	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−5,815 sh	$70.10	−$408K	11,858
2022-02-23	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−1,109 sh	$69.05	−$76.6K	4,926
2022-02-23	EXASEXACT SCIENCES CORP · Performance Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.7K sh	—	—	0
2022-02-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+12.7K sh	—	—	17,673
2022-02-22	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,247 sh	—	—	6,035
2022-02-22	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,247 sh	—	—	6,744
2022-02-15	EXASEXACT SCIENCES CORPS Sale	Director	SSale	−1,813 sh	$79.55	−$144K	3,788

Recent filings

Accepted (ET)
Oct 74
COWARD D SCOTT0001247296-26-000005
SEC(opens sec.gov)
Mar 234
COWARD D SCOTT0001193125-26-118752
SEC(opens sec.gov)
Jun 164
COWARD D SCOTT0000950170-25-086883
SEC(opens sec.gov)
Feb 214
COWARD D SCOTT0000950170-25-024895
SEC(opens sec.gov)
Dec 204/A
COWARD D SCOTT0000950170-24-139096
SEC(opens sec.gov)
Jun 174
COWARD D SCOTT0000950170-24-074410
SEC(opens sec.gov)
May 24
COWARD D SCOTT0000950170-24-052393
SEC(opens sec.gov)
Feb 234
COWARD D SCOTT0001209191-24-003919
SEC(opens sec.gov)
Feb 224
COWARD D SCOTT0001209191-24-003868
SEC(opens sec.gov)

Companies

Address

2525 EAST NORTH CAROLINA HIGHWAY 54

DURHAM, NC, 27713